AVGR News

Infraredx, which markets a FDA-cleared optical catheter that identifies lipid core coronary plaques, withdrew its plans for an initial public offering on Friday citing poor market conditions. It had planned to raise $56 million at a market cap of $214 million during late January, but postponed its offering. The Burlington, MA-based company was founded in 1998 and booked $5...read more

Ten IPOs raised $1.2 billion in a week dominated by eight health care IPOs and distinguished by two deals that gained over 100% on the first day - fast casual burger chain Shake Shack and gene therapy biotech Spark Therapeutics. There were more health care IPOs this past week than any week in 2014, a year that had over 100 from the sector. With 14 IPOs to date, January 2015 fell...read more

Avinger, which sells an image-guided, catheter-based system to treat peripheral arterial disease, raised $65 million by offering 5 million shares (upsized from 4.6 million shares) at $13, the midpoint of the $12 to $14. Avinger plans to list on the NASDAQ under the symbol AVGR. Avinger initially filed confidentially on 11/6/2014. Canaccord Genuity and Cowen & Company acted as...read more

Twelve IPOs are set to raise $1 billion in the upcoming week, which would make it the busiest five-day stretch for IPOs since the week of July 28. Shake Shack's IPO offers investors a chance to own a fast-growing fast casual concept based in New York. Ten of the twelve deals are health care, as last year's most popular sector continues to outperform. Assuming they all price, there...read more